PATENT CLAIM ANALYSIS

Application Number: 16122079
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "455000"]

Abstract:
This invention relates to a suppository composition comprising cannabinoids. The suppository composition is formulated for easy absorption through mucosal membrane. The suppository as provided herein is useful for administration of cannabinoids in patients with nausea, vomiting, other conditions preventing swallowing, or conditions wherein suppository administration is required. Methods to manufacture the suppository composition are provided. Methods to treat pain, nausea, post-operative ileus and/or inflammatory bowel diseases using the suppository according to this invention are also provided.

Claim (Index 13):
The method of  claim 12 , wherein the nausea or vomiting is chemotherapy related nausea or vomiting.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.59259
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15787978', '16106524', '14970322', '14684109', '12934633']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7952052994839293
- 35 USC 102 Novelty (BERT): 0.5825450090110251
- Combined Prediction Score: 0.7739392704366389
- Mean Citation Score: 338.877688
- Max Citation Score: 523.36707
- Similarity Product: 391.6324985006118

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test